Arrow Mark Colorado Holdings LLC Allakos Inc. Transaction History

Arrow Mark Colorado Holdings LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	BUY	$76.53 - $110.43 $9.65 Million - $13.9 Million	126,086 Added 38.26%	455,660 $48.2 Million
Q2 2021 Aug 16, 2021	SELL	$85.37 - $114.1 $1.88 Million - $2.52 Million	-22,065 Reduced 6.27%	329,574 $28.1 Million
Q1 2021 May 17, 2021	BUY	$109.73 - $153.66 $2.11 Million - $2.96 Million	19,267 Added 5.8%	351,639 $40.4 Million
Q4 2020 Feb 16, 2021	BUY	$79.58 - $152.45 $26.5 Million - $50.7 Million	332,372 New	332,372 $46.5 Million

64.7M

47.1K

Ticker ALLK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,726,096
Market Cap $91.5M
Description
Allakos Inc., a clinical stage biopharmaceutical company, develops therapeutics that target immunomodulatory receptors present on immune effector cells in allergy, inflammatory, and proliferative diseases. The company's lead monoclonal antibody is lirentelimab (AK002), which is in a Phase III study for the treatment of eosinophilic gastritis and...

Get notified when there are updates to the investment portfolio of Arrow Mark Colorado Holdings LLC, based on Form 13F filings with the SEC.

Stay updated on Arrow Mark Colorado Holdings LLC with notifications on news.